Literature DB >> 10514350

Dehydration behavior of eprosartan mesylate dihydrate.

J Sheng1, G M Venkatesh, S P Duddu, D J Grant.   

Abstract

Eprosartan mesylate (SKF 108566-J; EM) is an antihypertensive agent approved for marketing in the USA. EM dihydrate was prepared by three methods, one of which included suspending the anhydrous drug in an aqueous solution of 1.0 M methanesulfonic acid to form a slurry, followed by filtration. The dehydration kinetics of EM dihydrate were derived by analyzing the fit of the isothermal thermogravimetric analytical (TGA) data to numerous kinetic models. EM dihydrate undergoes dehydration in two distinct steps, each involving the loss of 1 mol of water at 25-70 degrees C and 70-120 degrees C, respectively. Recrystallization of EM occurs at approximately 120-140 degrees C after dehydration to the anhydrous phase. This explanation is supported by variable temperature powder X-ray diffractometry. The mechanism of the dehydration reaction is complex, the dependence of the reaction rate on temperature varying as a function of the particles size. For the dihydrate of sieve fraction <125 microm, the kinetics of the first and second dehydration steps are consistent with the Avrami-Erofeev equation (A3, n = 1/3) over the temperature range studied, corresponding to three-dimensional growth of nuclei. In contrast, for the 125-180-microm and 180-250-microm sieve fractions, the kinetics are best described by the two-dimensional phase boundary reaction (R2) at a lower dehydration temperature (i.e., 28.3 degrees C), and by the Avrami-Erofeev equation (A3, n = 1/3) at a higher dehydration temperature (i.e., 93.7 degrees C). The activation energies (15-40 kcal/mol) and frequency factors of the dehydration of EM dihydrate were determined both by Arrhenius plots of the isothermal rates determined by TGA and by Kissinger plots of the nonisothermal differential scanning calorimetric data. Hot stage microscopy of single crystals of EM dihydrate showed random nucleation at the surface and dehydration with the growth of microcrystals along the needle a axis. Cerius(2) molecular modeling software showed the existence of water channels along the a axis and enabled the observed dehydration behavior of EM dihydrate crystals to be explained in terms of the bonding environment of water molecules in the crystal structure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514350     DOI: 10.1021/js9900250

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Effect of salt type on hygroscopicity of a new cephalosporin S-3578.

Authors:  Kohsaku Kawakami; Yasuo Ida; Tohru Yamaguchi
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

2.  Effect of counterion on the solid state photodegradation behavior of prazosin salts.

Authors:  Lokesh Kumar; Rajan Jog; Saranjit Singh; Arvind Bansal
Journal:  AAPS PharmSciTech       Date:  2013-04-18       Impact factor: 3.246

3.  Rapid insight into heating-induced phase transformations in the solid state of the calcium salt of atorvastatin using multivariate data analysis.

Authors:  Niels Peter Aae Christensen; Bernard Van Eerdenbrugh; Kaho Kwok; Lynne S Taylor; Andrew D Bond; Thomas Rades; Jukka Rantanen; Claus Cornett
Journal:  Pharm Res       Date:  2012-11-10       Impact factor: 4.200

4.  Eprosartan mesylate, an angiotensin II receptor antagonist.

Authors:  Jing-Jing Qian; Xiu-Rong Hu; Jianming Gu; Su-Xiang Wu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-02

5.  Imaging of dehydration in particulate matter using Raman line-focus microscopy.

Authors:  Peter Ouma Okeyo; Oleksii Ilchenko; Roman Slipets; Peter Emil Larsen; Anja Boisen; Thomas Rades; Jukka Rantanen
Journal:  Sci Rep       Date:  2019-05-17       Impact factor: 4.379

6.  Non-isothermal dehydration kinetic study of aspartame hemihydrate using DSC, TGA and DSC-FTIR microspectroscopy.

Authors:  Wei-Hsien Hsieh; Wen-Ting Cheng; Ling-Chun Chen; Shan-Yang Lin
Journal:  Asian J Pharm Sci       Date:  2017-12-08       Impact factor: 6.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.